Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inequitable Conduct: Drug Industry Implores Federal Circuit To Revise Standard For Finding Deception In Patent Prosecution

Executive Summary

The pharmaceutical industry has jumped at the opportunity to weigh in on a case that could change how courts determine whether patent owners deceived the U.S. Patent and Trademark Office in obtaining their patents

You may also be interested in...



Inequitable Conduct "Plague" Cured By Federal Circuit's Therasense Decision

Alleged infringers will have a tougher time proving that a patent applicant deceived the patent office under a new standard set by the U.S. Court of Appeals for the Federal Circuit.

Inequitable Conduct "Plague" Cured By Federal Circuit's Therasense Decision

Alleged infringers will have a tougher time proving that a patent applicant deceived the patent office under a new standard set by the U.S. Court of Appeals for the Federal Circuit.

House Patent Reform Bill: Battle Looms Over Reexam, Prior User Rights Provisions

The six-year battle over patent reform legislation is not yet over as the pharmaceutical and biotechnology industries and other leading stakeholders are unhappy with provisions in the House bill that differ from the recently passed Senate measure.

Related Content

Topics

UsernamePublicRestriction

Register

PS052533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel